Extracellular matrix metalloproteinase inducer: A novel poor prognostic marker for human seminomas

Clinical and Translational Oncology

Volumn 14, Issue 3, 2012, Pages 190-196

  Bi, Xue Cheng ^a   Liu, Jiu Min ^a   He, Hui Chan ^b,c   Ye, Yong Kang ^b,c   Han, Zhao Dong ^b,c   Dai, Qi Shan ^b,c   Liang, Yu Xiang ^b,c   Chao Cai, ^b,c   Chen, Jia Hong ^b,c   Chen, Xi Bin ^b,c   Qin, Guo Qiang ^b,c   Zeng, Guo Hua ^d   Zhong, Wei De ^b,c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Guangdong Key Laboratory of Urology   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathology; Extracellular matrix metalloproteinase inducer; Immunohistochemistry; Prognosis; Seminoma

Indexed keywords

CD147 ANTIGEN; GELATINASE A;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; PROTEIN EXPRESSION; SEMINOMA; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD147; CASE-CONTROL STUDIES; CHILD; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84860777131     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0783-5     Document Type: Article

References (32)

1. Shigeyuki Y, Kazuyoshi K, Tomohiko I (2004) Gene expression pro? ling identi? es a set of transcripts that are up-regulated in human testicular seminoma. DNA Res 11:335-344
2. Albers P, Albrecht W, Algaba F (2005) Guidelines on testicular cancer. Eur Urol 48:885-894 (Pubitemid 41641630)
3. Skakkebaek NE, Rajpert-De, Meyts E (2007) Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. Int J Androl 30:198-204 (Pubitemid 47254416)
4. Sean KL, Lawrence MW, Peiguo GC (2007) D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30. Mod Pathol 20:320-325
5. Biermann K, Goke F, Nettersheim D (2007) cKIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213:311-318 (Pubitemid 350074021)
6. Yukinari K, Isoji S, Mika K (2004) Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. Oncogene 23:8552-8556
7. Biswas C, Zhang Y, DeCastro R et al (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439
8. Stanley Z, Michelle H, Ellen ER (2001) Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 158:1921-1928
9. Guo H, Majmudar G, Jensen TC et al (1998) Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 220:99-108 (Pubitemid 28470328)
10. Guo H, Zucker S, Gordon MK et al (1997) Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272:24-27 (Pubitemid 27021117)
11. Zucker S, Hymowitz M, Rollo EE (2001) Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 158:1921-1928 (Pubitemid 32545174)
12. Ladanyi M, Antonescu CR, Drobnjak M et al (2002) The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am J Pathol 160: 1215-1221 (Pubitemid 34411625)
13. Sun J, Hemler ME (2001) Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 6:2276-2281 (Pubitemid 32692059)
14. Tsai WC, Sheu LF, Nieh S (2007) Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters. World J Urol 25:73-80
15. Mi Z, Oliver T, Guo H (2007) Thrombin-cleaved COOH (-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Cancer Res 67:4088-4097 (Pubitemid 46815053)
16. Qian AR, Zhang W, Cao JP (2008) Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. J Exp Clin Cancer Res 27:50
17. Han ZD, He HC, Bi XC et al (2010) Expression and clinical signi? cance of CD147 in genitourinary carcinomas. J Surg Res 160:260-267
18. Han ZD, Bi XC, Qin WJ et al (2009) CD147 expression indicates unfavourable prognosis in prostate cancer. Pathol Oncol Res 15:369-374
19. Zhong WD, Han ZD, He HC (2008) CD147, MMP-1, MMP-2 and MMP-9 protein expression as signi? cant prognostic factors in human prostate cancer. Oncology 75:230-236
20. Tang Y, Prabakaran K, Marian T (2004) Tumorstroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2:73-80 (Pubitemid 38250423)
21. Pauls K, Merkelbach-Bruse S, Thal D (2005) PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology 46:166-175 (Pubitemid 40293015)
22. Cheng MF, Tzao C, Tsai WC (2006) Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus 19:482-486 (Pubitemid 44644686)
23. Restucci B, Maiolino P, Paciello O (2003) Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry. J Comp Pathol 128:252-259 (Pubitemid 36531660)
24. Valdevenito JP, Gallegos I, Fernández C et al (2007) Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma. Urology 70:777-780 (Pubitemid 350030216)
25. López-Otín C, Palavalli LH, Samuels Y (2009) Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle 8:3657-3662
26. Palavalli LH, Prickett TD, Wunderlich JR et al (2009) Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 41:518-520
27. Garg P, Sarma D, Jeppsson S et al (2010) Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res 70:792-801
28. Lee JW, Song SY, Choi JJ (2005) Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum Pathol 36:626-633
29. Jia L, Cao J, Wei W et al (2007) CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells. Int J Biochem Cell Biol 39:2135-2142 (Pubitemid 47369245)
30. Zhong WD, Han ZD, He HC (2008) CD147, MMP-1, MMP-2 and MMP-9 protein expression as signi? cant prognostic factors in human prostate cancer. Oncology 75:230-236
31. Qian AR, Zhang W, Cao JP (2008) Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. J Exp Clin Cancer Res 27:50
32. Nabeshima K, Iwasaki H, Koga K (2006) Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56:359-367 (Pubitemid 43886799)